AIM webinar on the FDA’s Patient-Focused Drug Development (PFDD) Initiative
Date: February 02, 2017
The U.S. Food & Drug Administration (FDA) is holding a public meeting on April 6, 2017 to hear directly from patients, caregivers and advocates about sarcopenia. This Patient-Focused Drug Development (PFDD) Meeting is a rare opportunity to talk with the FDA about what it is like to live with the condition and how improved treatment could impact your life. The Aging In Motion (AIM) Coalition’s one-hour webinar on Wednesday, February 15, 2017 will provide background on the FDA’s PFDD Initiative, detail what will be expected of participants at this meeting, and highlight real patient experiences from a PFDD meeting. Register here.